• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项儿科体重管理计划的估计成本及成本效益

Estimated Costs and Cost-Effectiveness of a Pediatric Weight Management Program.

作者信息

Simione Meg, Wagner Sophie, Kistin Caroline J, Egan Kelsey A, Kelly Sheila, Adams William G, Taveras Elsie M, Hur Chin

机构信息

Department of Pediatrics, Mass General for Children, Boston, Massachusetts.

Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.

出版信息

JAMA Netw Open. 2025 May 1;8(5):e2510087. doi: 10.1001/jamanetworkopen.2025.10087.

DOI:10.1001/jamanetworkopen.2025.10087
PMID:40366655
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12079289/
Abstract

IMPORTANCE

Childhood obesity remains a significant public health challenge, with ongoing racial, ethnic, and socioeconomic disparities in its prevention and treatment. Economic evaluations of pediatric obesity interventions are essential for guiding resource allocation in health care settings.

OBJECTIVE

To develop and analyze a simulation model of the Connect for Health program to estimate the costs of implementing the program and assess its cost-effectiveness.

DESIGN, SETTING, AND PARTICIPANTS: This economic evaluation used a Markov cohort model based on the Connect for Health randomized clinical trial (RCT) conducted from June 2014 through March 2016 and the Connect for Health implementation study conducted at 2 academic medical centers in Boston, MA. The study first estimated costs of implementation for new sites, and then simulated program implementation in a cohort that mirrored the RCT population. Data were analyzed from October 2023 to March 2025.

EXPOSURE

The Connect for Health pediatric weight management program.

MAIN OUTCOMES AND MEASURES

Outcomes include costs associated with program implementation and the incremental cost-effectiveness ratio (ICER) per quality-adjusted life-year (QALY) gained.

RESULTS

This study used a cohort of 2494 individuals to mirror the RCT population and included 1178 female participants (47%), a mean (SD) age of 8.0 (3.0) years, and a mean (SD) body mass index z score of 1.91 (0.56). The costs of implementing the Connect for Health program in primary care settings were estimated at $58 000 in 1-time startup costs and $1300 in ongoing monthly costs. The economic model showed that the Connect for Health strategy had an ICER of $10 554 per QALY gained over 2 years compared with no intervention. The study found a threshold of 534 children in a cohort was needed to effectively amortize costs.

CONCLUSIONS AND RELEVANCE

In this economic evaluation of a pediatric weight management program, the Connect for Health program was estimated to be cost-effective. These findings are important for health care systems that serve children who are less likely to receive obesity-related care in making decisions about program adoption.

摘要

重要性

儿童肥胖仍然是一项重大的公共卫生挑战,在其预防和治疗方面存在持续的种族、族裔和社会经济差异。对儿科肥胖干预措施进行经济评估对于指导医疗保健机构的资源分配至关重要。

目的

开发并分析“健康互联”项目的模拟模型,以估算实施该项目的成本并评估其成本效益。

设计、背景和参与者:这项经济评估使用了一个马尔可夫队列模型,该模型基于2014年6月至2016年3月进行的“健康互联”随机临床试验(RCT)以及在马萨诸塞州波士顿的2家学术医疗中心进行的“健康互联”实施研究。该研究首先估算新站点的实施成本,然后在一个反映RCT人群的队列中模拟项目实施情况。数据于2023年10月至2025年3月进行分析。

暴露因素

“健康互联”儿科体重管理项目。

主要结局和指标

结局包括与项目实施相关的成本以及每获得一个质量调整生命年(QALY)的增量成本效益比(ICER)。

结果

本研究使用了一个由2494名个体组成的队列来反映RCT人群,其中包括1178名女性参与者(47%),平均(标准差)年龄为8.0(3.0)岁,平均(标准差)体重指数z评分为1.91(0.56)。在初级保健机构实施“健康互联”项目的成本估计为一次性启动成本58000美元和每月持续成本1300美元。经济模型显示,与不进行干预相比,“健康互联”策略在2年内每获得一个QALY的ICER为10554美元。该研究发现,一个队列中需要有534名儿童才能有效摊销成本。

结论和意义

在这项对儿科体重管理项目的经济评估中,“健康互联”项目被估计具有成本效益。这些发现对于为不太可能接受肥胖相关护理的儿童提供服务的医疗保健系统在决定采用该项目时具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d6/12079289/0c80b71a8510/jamanetwopen-e2510087-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d6/12079289/0c80b71a8510/jamanetwopen-e2510087-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d6/12079289/0c80b71a8510/jamanetwopen-e2510087-g001.jpg

相似文献

1
Estimated Costs and Cost-Effectiveness of a Pediatric Weight Management Program.一项儿科体重管理计划的估计成本及成本效益
JAMA Netw Open. 2025 May 1;8(5):e2510087. doi: 10.1001/jamanetworkopen.2025.10087.
2
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
3
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.
4
Clinical effectiveness and cost-effectiveness of laparoscopic surgery for colorectal cancer: systematic reviews and economic evaluation.腹腔镜手术治疗结直肠癌的临床疗效与成本效益:系统评价与经济学评估
Health Technol Assess. 2006 Nov;10(45):1-141, iii-iv. doi: 10.3310/hta10450.
5
The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.心脏再同步治疗(双心室起搏)用于心力衰竭的临床疗效及成本效益:系统评价与经济学模型
Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. doi: 10.3310/hta11470.
6
Economic evaluations of adult weight management interventions: a systematic literature review focusing on methods used for determining health impacts.成人体重管理干预措施的经济评价:一项侧重于确定健康影响的方法的系统文献综述
Appl Health Econ Health Policy. 2012 May 1;10(3):145-62. doi: 10.2165/11599250-000000000-00000.
7
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
8
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
9
A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.对不同患者群体中植入式心脏复律除颤器治疗的效果和成本相关证据的综述,以及在英国背景下对这些群体的成本效益和成本效用进行建模。
Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. doi: 10.3310/hta10270.
10
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.巴雷特食管的监测:通过系统评价、专家研讨会和经济模型探索不确定性
Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080.

本文引用的文献

1
Interventions for Weight Management in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.儿童和青少年体重管理干预措施:美国预防服务工作组的更新证据报告和系统评价。
JAMA. 2024 Jul 16;332(3):233-248. doi: 10.1001/jama.2024.6739.
2
Interventions for High Body Mass Index in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.儿童和青少年高身体质量指数的干预措施:美国预防服务工作组推荐声明。
JAMA. 2024 Jul 16;332(3):226-232. doi: 10.1001/jama.2024.11146.
3
Costs to Implement a Pediatric Weight Management Program Across 3 Distinct Contexts.
在 3 个不同环境中实施儿科体重管理项目的成本。
Med Care. 2023 Oct 1;61(10):715-725. doi: 10.1097/MLR.0000000000001891. Epub 2023 Sep 7.
4
Cost-Effectiveness of Pharmacotherapy for the Treatment of Obesity in Adolescents.青少年肥胖症治疗药物治疗的成本效益分析。
JAMA Netw Open. 2023 Aug 1;6(8):e2329178. doi: 10.1001/jamanetworkopen.2023.29178.
5
A systematic review of economic evaluations of interventions targeting childhood overweight and obesity.系统评价干预措施针对儿童超重和肥胖的经济评估。
Obes Rev. 2023 Sep;24(9):e13597. doi: 10.1111/obr.13597. Epub 2023 Jul 18.
6
Cost-Effectiveness and Long-Term Savings of the Bright Bodies Intervention for Childhood Obesity.《明亮身体干预儿童肥胖的成本效益和长期储蓄》
Value Health. 2023 Aug;26(8):1183-1191. doi: 10.1016/j.jval.2023.03.006. Epub 2023 Mar 24.
7
Primary prevention programs for childhood obesity: are they cost-effective?儿童肥胖的一级预防计划:它们具有成本效益吗?
Ital J Pediatr. 2023 Mar 2;49(1):28. doi: 10.1186/s13052-023-01424-9.
8
Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity.儿童和青少年肥胖评估与治疗临床实践指南
Pediatrics. 2023 Feb 1;151(2). doi: 10.1542/peds.2022-060640.
9
Cost-effectiveness of a motivational interviewing obesity intervention versus usual care in pediatric primary care offices.动机性访谈肥胖干预与儿科初级保健办公室常规护理的成本效益比较。
Obesity (Silver Spring). 2022 Nov;30(11):2265-2274. doi: 10.1002/oby.23560.
10
Economic evaluation of the Communicating Healthy Beginnings Advice by Telephone trial for early childhood obesity prevention.通过电话对儿童早期肥胖预防进行沟通健康开端建议的经济评估试验。
Obesity (Silver Spring). 2022 Nov;30(11):2256-2264. doi: 10.1002/oby.23547. Epub 2022 Sep 27.